시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 급성 인두염 시장 보고서(2025년)
Acute Pharyngitis Global Market Report 2025
상품코드 : 1720694
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,342,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,167,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,992,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

급성 인두염 시장 규모는 향후 수년간 급성장이 예상될 예정입니다. 예측 기간을 형성할 것으로 예상되는 주요 동향에는 시판의 치료제으로의 시프트, 병용 요법 증가, 인두염의 진단에 있어서의 원격 의료의 확대, 자연 요법이나 대체 요법의 인기가 높아짐, 셀프 케어나 집에서의 치료에 대한 기호의 고조 등이 있습니다.

인플루엔자의 유행 증가는 급성 인두염 시장의 성장을 견인할 것으로 예측됩니다. 백신 접종률 감소, 사람 이동 증가, 바이러스 돌연변이, 특정 집단의 면역력 저하 등의 요인이 인플루엔자 환자 증가에 기여하고 있습니다. 예방관리센터(CDC)의 보고에 따르면, 인플루엔자의 임상검사에서는 31.6%가 양성이며, 전주의 29.4%, 연초의 18.6%에서 증가하고 있습니다.

급성 인두염 시장의 기업은 세균 감염을 보다 효과적으로 치료하고 항생제 내성을 줄이기 위한 항생제 개발에 주력하고 있습니다. 예를 들어, 2022년 2월 인도에 본사를 둔 알레믹 파마슈티컬스 리미티드는 250mg 및 500mg 용량으로 제공되는 클라리트로마이신 정제에 대해 미국 식품의약국(FDA)으로부터 약식 신약 신청(ANDA)을 승인받았습니다. 폐렴, 만성 기관지염과 같은 경미한 중등도의 박테리아 감염을 치료하는 데 사용됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Acute pharyngitis is the inflammation of the pharynx, a part of the throat located behind the mouth and nasal cavity, commonly causing a sore throat along with symptoms such as fever, headache, and swollen lymph nodes. This condition is most often caused by viral infections, though bacterial and fungal infections can also be responsible.

The primary treatments for acute pharyngitis include antibiotics, antivirals, over-the-counter (OTC) medications, corticosteroids, anti-inflammatory drugs, and alternative remedies. Antibiotics are used to treat bacterial infections by killing bacteria or inhibiting their growth. These treatments are distributed through various channels such as hospital pharmacies, online pharmacies, and retail pharmacies, with key end-users including hospitals, homecare settings, specialty centers, and other healthcare providers.

The acute pharyngitis market research report is one of a series of new reports from The Business Research Company that provides acute pharyngitis market statistics, including acute pharyngitis industry global market size, regional shares, competitors with an acute pharyngitis market share, detailed acute pharyngitis market segments, market trends and opportunities, and any further data you may need to thrive in the acute pharyngitis industry. This acute pharyngitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acute pharyngitis market size has grown strongly in recent years. It will grow from $2.67 billion in 2024 to $2.90 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to several factors, including the rising incidence of viral and bacterial infections, which have contributed to the increased demand for treatments. Additionally, growing healthcare awareness has led to earlier diagnosis and better management of acute pharyngitis. Advancements in diagnostic technologies have made it easier to identify the cause of infections, while the rising number of pediatric cases has further driven the market. Moreover, an increase in environmental pollutants and allergens has contributed to a higher prevalence of throat-related conditions.

The acute pharyngitis market size is expected to see rapid growth in the next few years. It will grow to $3.98 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The projected growth during the forecast period can be linked to factors such as the increasing prevalence of influenza and streptococcal infections, a stronger emphasis on personalized medicine, higher adoption rates of rapid diagnostic tests, advancements in healthcare infrastructure, and broader healthcare access in emerging markets. Key trends expected to shape the forecast period include a shift toward over-the-counter treatments, a rise in the use of combination therapies, the expansion of telemedicine for diagnosing pharyngitis, growing popularity of natural and alternative remedies, and an increasing preference for self-care and home treatments.

The increasing prevalence of influenza is expected to drive the growth of the acute pharyngitis market. Influenza is caused by infection with influenza viruses, which spread through respiratory droplets from coughs, sneezes, or contact with contaminated surfaces. Factors such as seasonal changes, low vaccination rates, increased human mobility, viral mutations, and weakened immunity in certain populations contribute to the rise in influenza cases. Acute pharyngitis treatment helps alleviate throat inflammation and pain in influenza patients, reducing discomfort while swallowing, preventing secondary bacterial infections, and supporting overall recovery. When combined with antiviral medications, proper hydration, and rest, these treatments enhance the body's ability to combat the influenza virus. For example, as of February 2025, the Centers for Disease Control and Prevention (CDC) reported that 31.6% of clinical lab tests for influenza were positive, up from 29.4% the previous week and 18.6% at the start of the year. This increase in influenza cases is contributing to the growth of the acute pharyngitis market.

Companies in the acute pharyngitis market are focusing on developing antibiotics to treat bacterial infections more effectively and reduce antibiotic resistance. Antibiotics are essential for treating acute pharyngitis caused by bacterial infections, such as streptococcus pyogenes, by eliminating the bacteria, reducing symptoms, and preventing complications such as rheumatic fever. For example, in February 2022, Alembic Pharmaceuticals Limited, an India-based company, received Abbreviated New Drug Application (ANDA) approval from the US Food and Drug Administration (FDA) for Clarithromycin tablets, available in 250 mg and 500 mg dosages. This macrolide antibiotic is used to treat mild to moderate bacterial infections, including pharyngitis, tonsillitis, community-acquired pneumonia, and chronic bronchitis. The approval highlights the importance of effective antimicrobial treatments in managing acute pharyngitis and other related bacterial infections.

In November 2022, TPG Inc., a US-based private equity firm, acquired a majority stake in iNova Pharmaceuticals for $1.3 billion. With this acquisition, TPG Inc. aims to accelerate growth, expand market reach, and enhance its product offerings in the healthcare sector, particularly in Southeast and North Asia. iNova Pharmaceuticals, based in Singapore, focuses on providing over-the-counter products designed to relieve pharyngitis symptoms, such as throat lozenges and pain relievers.

Major players in the acute pharyngitis market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb, AstraZeneca plc, Novartis AG, Glaxo Smithkline Pharmaceuticals Ltd, F. Hoffmann-La Roche AG, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz Group AG, Bitop AG, Hikma Pharmaceuticals, Lupin Limited, Alkem Laboratories Ltd., MEDICE Arzneimittel Putter GmbH & Co. KG, MCM Klosterfrau Vertriebsgesellschaft mbH.

North America was the largest region in the acute pharyngitis market in 2024. The regions covered in acute pharyngitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Acute Pharyngitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acute pharyngitis market consists of revenues earned by entities by providing services such as diagnostic testing services, pharmaceutical dispensing services, and preventive and vaccination services. The market value includes the value of related goods sold by the service provider or included within the service offering. The acute pharyngitis market also includes sales of penicillin, amoxicillin, azithromycin, throat gargles and rinses. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Pharyngitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acute pharyngitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for acute pharyngitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acute pharyngitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Acute Pharyngitis Market Characteristics

3. Acute Pharyngitis Market Trends And Strategies

4. Acute Pharyngitis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Acute Pharyngitis Growth Analysis And Strategic Analysis Framework

6. Acute Pharyngitis Market Segmentation

7. Acute Pharyngitis Market Regional And Country Analysis

8. Asia-Pacific Acute Pharyngitis Market

9. China Acute Pharyngitis Market

10. India Acute Pharyngitis Market

11. Japan Acute Pharyngitis Market

12. Australia Acute Pharyngitis Market

13. Indonesia Acute Pharyngitis Market

14. South Korea Acute Pharyngitis Market

15. Western Europe Acute Pharyngitis Market

16. UK Acute Pharyngitis Market

17. Germany Acute Pharyngitis Market

18. France Acute Pharyngitis Market

19. Italy Acute Pharyngitis Market

20. Spain Acute Pharyngitis Market

21. Eastern Europe Acute Pharyngitis Market

22. Russia Acute Pharyngitis Market

23. North America Acute Pharyngitis Market

24. USA Acute Pharyngitis Market

25. Canada Acute Pharyngitis Market

26. South America Acute Pharyngitis Market

27. Brazil Acute Pharyngitis Market

28. Middle East Acute Pharyngitis Market

29. Africa Acute Pharyngitis Market

30. Acute Pharyngitis Market Competitive Landscape And Company Profiles

31. Acute Pharyngitis Market Other Major And Innovative Companies

32. Global Acute Pharyngitis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acute Pharyngitis Market

34. Recent Developments In The Acute Pharyngitis Market

35. Acute Pharyngitis Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기